2019
DOI: 10.21856/j-pep.2019.4.16
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: красова н. с. 1 , гладких о. і. 1 , яременко Ф. г. 1 , тижненко т. в. 1,2 , лещенко Ж. а. 1 , свидло і. м. 1 , громаковська о. б. 1 , овсяннікова т. м. 2 , коваленко а. о. 2 , ліпсон в. в. 1 , полторак в. в. 1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…This is consistent with our results, but there is no evidence of earlier symptoms of insulin resistance. It should be noted that longer use of HFD is also accompanied by the development of obesity (Krasova et al, 2019). Despite the fact that in clinical medicine, obesity is considered the main cause of the development of insulin resistance, the interaction of these pathogenetic components of the metabolic syndrome currently appears to be more complex and is still the subject of discussion (Tanase et al, 2020;Gołacki et al, 2022).…”
Section: Discussionmentioning
confidence: 99%
“…This is consistent with our results, but there is no evidence of earlier symptoms of insulin resistance. It should be noted that longer use of HFD is also accompanied by the development of obesity (Krasova et al, 2019). Despite the fact that in clinical medicine, obesity is considered the main cause of the development of insulin resistance, the interaction of these pathogenetic components of the metabolic syndrome currently appears to be more complex and is still the subject of discussion (Tanase et al, 2020;Gołacki et al, 2022).…”
Section: Discussionmentioning
confidence: 99%